Grants paid by Pediatric Cancer Research Foundation
EIN 95-3772528 · Irvine, CA · Form 990, Schedule I
Pediatric Cancer Research Foundation of Irvine, CA (EIN 95-3772528) reported 99 grants paid totaling $9,835,737 to 34 recipients in tax years 2018–2025, on Form 990, Schedule I. Derived from IRS e-file data, dataset version 2026.09.0, built 2026-09-03.
Grants paid
$9,835,737
99 grants
Recipients
34
distinct organizations
Tax years
2018–2025
7 filings in the corpus
By tax year
| Tax year | Grants paid | Amount paid | Approved for future |
|---|---|---|---|
| 2018 | 12 | $0 | — |
| 2020 | 14 | $1,945,090 | — |
| 2021 | 13 | $1,944,660 | — |
| 2022 | 16 | $1,929,700 | — |
| 2023 | 15 | $1,645,724 | — |
| 2024 | 14 | $824,563 | — |
| 2025 | 15 | $1,546,000 | — |
Top recipients
The 34 recipients receiving the most from Pediatric Cancer Research Foundation, by grants paid, out of 34 distinct recipients.
| Recipient | Match | Location | Grants | Total paid | Latest year |
|---|---|---|---|---|---|
| New York Medical College 13-1099420 | A | Valhalla, NY | 7 | $3,805,000 | 2025 |
| Dana-Farber Cancer Institute 04-2263040 | A | Boston, MA | 7 | $585,500 | 2025 |
| Stanford University 94-1156365 | A | Palo Alto, CA | 7 | $560,500 | 2025 |
| Ann & Robert Lurie Children's Hospital 36-2170833 | A | Chicago, IL | 5 | $456,250 | 2022 |
| University of California San Francisco 94-6036493 | A | San Francisco, CA | 6 | $436,250 | 2025 |
| University of Texas Md Anderson Cancer Center 76-6001118 | A | Houston, TX | 5 | $429,217 | 2023 |
| Memorial Sloan Kettering 13-1924236 | A | New York, NY | 4 | $375,000 | 2025 |
| Children's Hospital of Philadelphia Research Institute 23-1352166 | A | Philadelphia, PA | 4 | $367,500 | 2024 |
| Case Western Reserve University School of Medicine 34-1018992 | A | Cleveland, OH | 5 | $255,000 | 2025 |
| Seattle Children's Hospital 91-0564748 | A | Seattle, WA | 3 | $248,750 | 2022 |
| UCLA Foundation 95-2250801 | A | Los Angeles, CA | 4 | $245,000 | 2023 |
| Texas Children's Hospital 74-1100555 | A | Houston, TX | 3 | $225,000 | 2022 |
| V Foundation 13-3705951 | A | Cary, NC | 1 | $204,000 | 2025 |
| City of Hope | U | Duarte, CA | 4 | $200,000 | 2025 |
| Hope for Henry 20-0244173 | A | Washington, DC | 4 | $179,563 | 2025 |
| Beckman Research Institute of the City of Hope | U | Duarte, CA | 3 | $152,500 | 2021 |
| Baylor College of Medicine 74-1613878 | A | Houston, TX | 2 | $150,000 | 2023 |
| Johns Hopkins University 52-0595100 | A | Baltimore, MD | 2 | $150,000 | 2025 |
| University of Alabama at Birmingham 63-6005396 | A | Birmingham, AL | 2 | $149,007 | 2023 |
| Children's Hospital of Los Angeles 95-1690977 | A | Los Angeles, CA | 5 | $132,000 | 2025 |
| Lucille Packard Foundation 77-0440090 | A | Palo Alto, CA | 1 | $75,000 | 2020 |
| Indiana University 35-6001673 | A | Bloomington, IN | 2 | $57,000 | 2025 |
| New York University School of Medicine 13-5562308 | A | New York, NY | 1 | $50,000 | 2023 |
| Lucille Packard Children's Hospital 77-0003859 | A | Palo Alto, CA | 1 | $50,000 | 2022 |
| University of Florida 59-6002052 | A | Gainesville, FL | 1 | $50,000 | 2023 |
| Barrow Neurological Foundation 86-0174371 | A | Phoenix, AZ | 1 | $50,000 | 2021 |
| Children's Hospital of Orange County 95-6097416 | A | Orange, CA | 1 | $50,000 | 2021 |
| Mayo Clinic 41-6011702 | A | Rochester, MN | 1 | $50,000 | 2023 |
| University of Denver 84-0404231 | A | Aurora, CO | 1 | $35,000 | 2020 |
| Massachusetts General Hospital 04-1564655 | A | Boston, MA | 2 | $29,700 | 2022 |
| Ronald Mcdonald House Charities 95-3167869 | A | Los Angeles, CA | 1 | $25,000 | 2025 |
| Live Like Liv Foundation 27-2472834 | A | Saratoga Springs, NY | 1 | $8,000 | 2025 |
| Children's Hospitals and Clinics of Minnesota 41-1754276 | A | Minneapolis, MN | 1 | $0 | 2018 |
| Emory University 58-0566256 | A | Atlanta, GA | 1 | $0 | 2018 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Every grant
All 99 grant rows this organization reported, most recent first.
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2025 | New York Medical College Valhalla, NY | A | $550,000 | paid | PEDIATRIC CANCER RESEARCH FOUNDATION LABORATORY AT NEW YORK MEDICAL COLLEGE | 202600799349300310 |
| 2025 | V Foundation Cary, NC | A | $204,000 | paid | CANCER RESEARCH | 202600799349300310 |
| 2025 | Memorial Sloan Kettering New York, NY | A | $150,000 | paid | TOWARDS CURATIVE EPIGENETIC THERAPIES OF REFRACTORY PEDIATRIC SARCOMAS | 202600799349300310 |
| 2025 | City of Hope Duarte, CA | U | $100,000 | paid | SINGLE-CELL DISSECTING OF HIGH-RISK B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA | 202600799349300310 |
| 2025 | Johns Hopkins Baltimore, MD | A | $100,000 | paid | TARGETING SHP2 AS A THERAPEUTIC STRATEGY IN FUSION-NEGATIVE RHABDOMYOSARCOMA | 202600799349300310 |
| 2025 | Dana Farber Boston, MA | A | $100,000 | paid | ADVANCING LIQUID BIOPSIES TO THE CLINIC FOR PATIENTS WITH EWING SARCOMA | 202600799349300310 |
| 2025 | Stanford Palo Alto, CA | A | $100,000 | paid | TARGETING MITOCHONDRIAL PATHWAYS IN PEDIATRIC AML | 202600799349300310 |
| 2025 | University of California San Francisco San Francisco, CA | A | $45,000 | paid | A RISK STRATIFIED CLINICAL TRIAL FOR PATIENTS WITH NEWLY DIAGNOSED JUVENILE MYELOMONOCYTIC LEUKEMIA | 202600799349300310 |
| 2025 | Children's Hospital Los Angeles Los Angeles, CA | A | $37,500 | paid | PRECLINIAL STUDY TO TRANSLATE THERAPY USING DNA HYPOMETHYLATING AGENTS FOR PEDIATRIC HIGH GRADE GLIOMAS | 202600799349300310 |
| 2025 | Case Western Clevenland, OH | A | $37,500 | paid | USE OF MR FINGERPRINTING FOR DETERMINING RESPONSE TO IMMUNOTHERAPY IN PEDIATRIC BRAIN TUMORS | 202600799349300310 |
| 2025 | Children's Hospital Los Angeles Los Angeles, CA | A | $32,000 | paid | RESEARCH INTO MULTIDISCIPLINARY APPROACH TO SIGNIFICANTLY AND POSITIVELY IMPROVE THE QUALITY OF LIFE OF AND QUALITY OF CARE FOR CHILDREN AND YOUNG PEOPLE WITH CANCER | 202600799349300310 |
| 2025 | Hope for Henry Foundation Washington, DC | A | $30,000 | paid | REWARDING PEDIATRIC PATIENTS AND ELEVATING THEIR CARE | 202600799349300310 |
| 2025 | Indiana University Bloomington, IN | A | $27,000 | paid | DECODING METABOLIC DEPENDENCIES OF MPNSTS AND ITS MICROENVIRONMENT | 202600799349300310 |
| 2025 | Ronald Mcdonald House Charities Los Angeles, CA | A | $25,000 | paid | WILDFIRE RECOVERY FUNDING FOR FAMILIES OF CANCER PATIENTS AT THE LOS ANGELES RONALD MCDONALD HOUSE | 202600799349300310 |
| 2025 | Live Like Liv Foundation Saratoga Springs, NY | A | $8,000 | paid | SUPPORTS CHILDREN AND FAMILIES DEALING WITH SERIOUS CONDITIONS | 202600799349300310 |
| 2024 | New York Medical College Valhalla, NY | A | $275,000 | paid | PEDIATRIC CANCER RESEARCH FOUNDATION LABORATORY AT NEW YORK MEDICAL COLLEGE | 202521079349301112 |
| 2024 | Memorial Sloan Kettering New York, NY | A | $75,000 | paid | TOWARDS CURATIVE EPIGENETIC THERAPIES OF REFRACTORY PEDIATRIC SARCOMAS | 202521079349301112 |
| 2024 | City of Hope Duarte, CA | U | $50,000 | paid | SINGLE-CELL DISSECTING OF HIGH-RISK B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA | 202521079349301112 |
| 2024 | Dana Farber Boston, MA | A | $50,000 | paid | PROSPECTIVE VALIDATION OF A PROGNOSTIC LIQUID BIOPSY APPROACH FOR PEDIATRIC EWING SARCOMA | 202521079349301112 |
| 2024 | Stanford University Palo Alto, CA | A | $50,000 | paid | TARGETING MITOCHONDRIAL PATHWAYS IN PEDIATRIC AML | 202521079349301112 |
| 2024 | Johns Hopkins University Baltimore, MD | A | $50,000 | paid | TARGETING SHP2 AS A THERAPEUTIC STRATEGY IN FUSION-NEGATIVE RHABDOMYOSARCOMA | 202521079349301112 |
| 2024 | Hope for Henry Washington, DC | A | $49,563 | paid | REWARDING PEDIATRIC PATIENTS AND ELEVATING THEIR CARE | 202521079349301112 |
| 2024 | Ucsf San Francisco, CA | A | $40,000 | paid | TACL2020-004: A RISK STRATIFIED CLINICAL TRIAL FOR PATIENTS WITH NEWLY DIAGNOSED JUVENILE MYELOMONOCYTIC LEUKEMIA | 202521079349301112 |
| 2024 | Children's Hospital of Los Angeles Los Angeles, CA | A | $37,500 | paid | PRECLINIAL STUDY TO TRANSLATE THERAPY USING DNA HYPOMETHYLATING AGENTS FOR PEDIATRIC HIGH GRADE GLIOMAS | 202521079349301112 |
| 2024 | Case Western Clevenland, OH | A | $37,500 | paid | USE OF MR FINGERPRINTING FOR DETERMINING RESPONSE TO IMMUNOTHERAPY IN PEDIATRIC BRAIN TUMORS | 202521079349301112 |
| 2024 | Indiana University Bloomington, IN | A | $30,000 | paid | DECODING METABOLIC DEPENDENCIES OF MPNSTS AND ITS MICROENVIRONMENT | 202521079349301112 |
| 2024 | Children's Hospital of Philadelphia Philadelphia, PA | A | $30,000 | paid | ELUCIDATING HOW NF1 LOSS COOPERATES WITH SETD2 TO DRIVE PEDIATRIC HIGH-GRADE GLIOMA FORMATION | 202521079349301112 |
| 2024 | City of Hope Duarte, CA | U | $25,000 | paid | REPORTER T CELL LINE GENERATION | 202521079349301112 |
| 2024 | Children's Hospital of Los Angeles Los Angeles, CA | A | $25,000 | paid | PROJECT TO LEVERAGE THE POWER OF THE IMMUNE SYSTEM TO FIGHT PEDIATRIC HIGH-GRADE GLIOMA | 202521079349301112 |
| 2023 | New York Medical College Valhalla, NY | A | $550,000 | paid | PEDIATRIC CANCER RESEARCH FOUNDATION LABORATORY AT NEW YORK MEDICAL COLLEGE | 202402729349300305 |
| 2023 | Memorial Sloan Kettering New York, NY | A | $150,000 | paid | TOWARDS CURATIVE EPIGENETIC THERAPIES OF REFRACTORY PEDIATRIC SARCOMAS | 202402729349300305 |
| 2023 | Ucsf San Francisco, CA | A | $115,000 | paid | TACL2020-004: A RISK STRATIFIED CLINICAL TRIAL FOR PATIENTS WITH NEWLY DIAGNOSED JUVENILE MYELOMONOCYTIC LEUKEMIA | 202402729349300305 |
| 2023 | Stanford University Palo Alto, CA | A | $115,000 | paid | TARGETING MITOCHONDRIAL PATHWAYS IN PEDIATRIC AML | 202402729349300305 |
| 2023 | Dana Farber Boston, MA | A | $105,000 | paid | PROSPECTIVE VALIDATION OF A PROGNOSTIC LIQUID BIOPSY APPROACH FOR PEDIATRIC EWING SARCOMA | 202402729349300305 |
| 2023 | Md Anderson Houston, TX | A | $91,717 | paid | COMBINING A NOVEL DENDRITIC CELL VACCINE WITH CHECKPOINT BLOCKADE FOR OSTEOSARCOMA THERAPY | 202402729349300305 |
| 2023 | Case Western Clevenland, OH | A | $75,000 | paid | USE OF MR FINGERPRINTING FOR DETERMINING RESPONSE TO IMMUNOTHERAPY IN PEDIATRIC BRAIN TUMORS | 202402729349300305 |
| 2023 | Baylor College of Medicine Houston, TX | A | $75,000 | paid | OFF-THE-SHELF COMBINATION CANCER IMMUNOTHERAPY WITH ONCOLYTIC ADENO-IMMUNOTHERAPY AND CAR NK CELL THERAPY FOR PEDIATRIC SARCOMA | 202402729349300305 |
| 2023 | University of Alabama Birmingham Birmingham, AL | A | $74,007 | paid | INTRANASAL DELIVERY OF TARGETING NANOLIPOSOMAL THERAPEUTICS FOR PEDIATRIC GLIOMA | 202402729349300305 |
| 2023 | UCLA Foundation Los Angeles, CA | A | $70,000 | paid | RESEARCH INTO MULTIDISCIPLINARY APPROACH TO SIGNIFICANTLY AND POSITIVELY IMPROVE THE QUALITY OF LIFE OF AND QUALITY OF CARE FOR CHILDREN AND YOUNG PEOPLE WITH CANCER. | 202402729349300305 |
| 2023 | Mayo Clinic Rochester, MN | A | $50,000 | paid | TARGETING TRANSCRIPTIONAL DEPENDENCIES IN ATYPICAL TERATOID RHABDOID TUMOR | 202402729349300305 |
| 2023 | University of Florida Gainesville, FL | A | $50,000 | paid | INVESTIGATING THE IMMUNE RESPONSE TO RNA-LIPID NANOPARTICLE VACCINES IN A CLINICAL TRIAL FOR CANINES WITH OSTEOSARCOMA | 202402729349300305 |
| 2023 | New York University School of Medicine New York, NY | A | $50,000 | paid | MODULATING THE IMMUNE MICROENVIRONMENT IN PEDIATRIC ACUTE MYELOID LEUKEMIA | 202402729349300305 |
| 2023 | Hope for Henry Washington, DC | A | $50,000 | paid | REWARDING PEDIATRIC PATIENTS AND ELEVATING THEIR CARE | 202402729349300305 |
| 2023 | City of Hope Duarte, CA | U | $25,000 | paid | REPORTER T CELL LINE GENERATION | 202402729349300305 |
| 2022 | New York Medical College Valhalla, NY | A | $900,000 | paid | PEDIATRIC CANCER RESEARCH FOUNDATION LABORATORY AT NYMC | 202322719349302127 |
| 2022 | University of Texas Md Anderson Cancer Center Houston, TX | A | $125,000 | paid | COMBINING A NOVEL DENDRITIC CELL VACCINE WITH CHECKPOINT BLOCKADE FOR OSTEOSARCOMA THERAPY | 202322719349302127 |
| 2022 | Children's Hospital of Philadelphia Philadelphia, PA | A | $125,000 | paid | PRECISION MEDICINE TO EXPLOIT BCL2-FAMILY SURVIVAL DEPENDENCIES IN NEUROBLASTOMA | 202322719349302127 |
| 2022 | University of California San Francisco San Francisco, CA | A | $115,000 | paid | MODULATING THE IMMUNE MICROENVIRONMENT IN PEDIATRIC ACUTE MYELOID LEUKEMIA | 202322719349302127 |
| 2022 | Ann & Robert Lurie Children's Hospital Chicago, IL | A | $75,000 | paid | INTRANASAL DELIVERY OF TARGETING NANOLIPOSOMAL THERAPEUTICS FOR PEDIATRIC GLIOMA | 202322719349302127 |
| 2022 | Dana-Farber Cancer Institute Boston, MA | A | $75,000 | paid | PROSPECTIVE VALIDATION OF A PROGNOSTIC LIQUID BIOPSY APPROACH FOR PEDIATRIC EWING SARCOMA | 202322719349302127 |
| 2022 | University of Alabama at Birmingham Birmingham, AL | A | $75,000 | paid | ENHANCEMENT OF IMMUNOVIROTHERAPY WITH DIRECTED DRUG DELIVERY FOR TREATMENT OF PEDIATRIC HIGH-GRADE GLIOMA | 202322719349302127 |
| 2022 | Stanford University Palo Alto, CA | A | $75,000 | paid | DEVELOPMENT OF SMALL MOLECULES TO TARGET CRED:CBP INTERACTION FOR TREATMENT OF AML | 202322719349302127 |
| 2022 | Baylor College of Medicine Houston, TX | A | $75,000 | paid | OFF-THE-SHELF COMBINATION CANCER IMMUNOTHERAPY WITH ONCOLYTIC ADENO-IMMUNOTHERAPY AND CAR NK CELL THERAPY FOR PEDIATRIC SARCOMA | 202322719349302127 |
| 2022 | UCLA Foundation Los Angeles, CA | A | $55,000 | paid | RESEARCH INTO MULTIDISCIPLINARY APPROACH TO SIGNIFICANTLY AND POSITIVELY IMPROVE THE QUALITY OF LIFE AND QUALITY OF CARE FOR CHILDREN AND YOUNG PEOPLE WITH CANCER | 202322719349302127 |
| 2022 | Lucille Packard Children's Hospital Palo Alto, CA | A | $50,000 | paid | EFFECTIVE THERAPY FOR PEDIATRIC HIGH-GRADE GLIOMAS | 202322719349302127 |
| 2022 | Texas Children's Hospital Houston, TX | A | $50,000 | paid | DEVELOPING A SENSITIVE METHOD FOR CIC FUSION GENE DETECTION IN SARCOMAS BY CUSTOMIZED GENOMIC SEQUENCING | 202322719349302127 |
| 2022 | Hope for Henry Foundation Washington, DC | A | $50,000 | paid | REINVENTING HOW HOSPITALS CARE FOR SERIOUSLY ILL CHILDREN AND THEIR FAMILIES THROUGH INNOVATIVE PROGRAMS THAT ENTERTAIN, REDUCE STRESS, AND EMPOWER CHILDREN TO BE ACTIVE PARTICIPANTS IN THEIR OWN CARE. | 202322719349302127 |
| 2022 | Seattle Children's Hospital Seattle, WA | A | $30,000 | paid | DEVELOPMENT OF TUNABLE ON-OFF CAR T CELLS FOR SAFE AND DURABLE TUMOR CONTROL | 202322719349302127 |
| 2022 | Massachusetts General Hospital Boston, MA | A | $29,700 | paid | OPTIMIZING CAR T CELL IMMUNOTHERAPY FOR PEDIATRIC RHABDOMYOSARCOMA | 202322719349302127 |
| 2022 | Ann & Robert Lurie Children's Hospital Chicago, IL | A | $25,000 | paid | IMMUNOTHERAPY FOR DIPG | 202322719349302127 |
| 2021 | New York Medical College Valhalla, NY | A | $862,160 | paid | PEDIATRIC CANCER RESEARCH LABORATORY GRANT | 202202729349301750 |
| 2021 | Texas Children's Hospital Houston, TX | A | $125,000 | paid | RESEARCH INTO MOLECULAR CHARACTERIZATION OF UNDIFFERENTIATED SARCOMAS | 202202729349301750 |
| 2021 | Children's Hospital of Philadelphia Research Institute Philadelphia, PA | A | $125,000 | paid | BASIC RESEARCH SCIENCE GRANT PRECISION MEDICINE TO EXPLOIT BCL2-FAMILY SURVIVAL DEPENDENCIES IN NEUROBLASTOMA | 202202729349301750 |
| 2021 | Seattle Children's Hospital Seattle, WA | A | $125,000 | paid | BASIC RESEARCH SCIENCE GRANT DEVELOPMENT OF TUNABLE ON-OFF CAR T CELLS FOR SAFE AND DURABLE TUMOR CONTROL | 202202729349301750 |
| 2021 | Stanford University Palo Alto, CA | A | $125,000 | paid | BASIC RESEARCH SCIENCE GRANT DEVELOPMENT OF SMALL MOLECULES TO TARGET CREB:CBP INTERACTION FOR TREATMENT OF AML | 202202729349301750 |
| 2021 | University of Texas Md Anderson Cancer Center Houston, TX | A | $125,000 | paid | BASIC RESEARCH SCIENCE GRANT COMBINING A NOVEL DENDRITIC CELL VACCINE WITH CHECKPOINT BLOCKADE FOR OSTEOSARCOMA THERAPY | 202202729349301750 |
| 2021 | Dana-Farber Cancer Institute Boston, MA | A | $87,500 | paid | BASIC RESEARCH SCIENCE GRANT PROSPECTIVE VALIDATION OF A PROGNOSTIC LIQUID BIOPSY APPROACH FOR PEDIATRIC EWING SARCOMA | 202202729349301750 |
| 2021 | Beckman Research Institute of the City of Hope Duarte, CA | U | $75,000 | paid | TRANSLATIONAL RESEARCH GRANT FINE-TUNING CHIMERIC ANTIGEN RECEPTOR SIGNALING TO IMPROVE CAR T CELL THERAPY FOR PEDIATRIC BRAIN TUMORS | 202202729349301750 |
| 2021 | UCLA Foundation Los Angeles, CA | A | $70,000 | paid | RESEARCH INTO MULTIDISCIPLINARY APPROACH TO SIGNIFICANTLY AND POSITIVELY IMPROVE THE QUALITY OF LIFE AND QUALITY OF CARE FOR FOR CHILDREN AND YOUNG PEOPLE WITH CANCER | 202202729349301750 |
| 2021 | University of California San Francisco San Francisco, CA | A | $65,000 | paid | TRANSLATIONAL RESEARCH GRANT A RISK STRATIFIED CLINICAL TRIAL FOR PATIENTS WITH NEWLY DIAGNOSED JUVENILE MYELOMONOCYTIC LEUKEMIA | 202202729349301750 |
| 2021 | Ann & Robert Lurie Children's Hospital Chicago, IL | A | $60,000 | paid | RESEARCH INTO THE EPIGENETIC TARGETED THERAPY FOR PEDIATRIC MALIGNANT BRAIN TUMORS | 202202729349301750 |
| 2021 | Children's Hospital of Orange County Orange, CA | A | $50,000 | paid | RESEARCH INTO NOVEL AND TARGETED TREATMENT TO ADDRESS THE HIGH MORBIDITY AND MORTALITY OF PEDIATRIC CNS MALIGNANCIES AND MEDULLOBLASTOMA | 202202729349301750 |
| 2021 | Barrow Neurological Foundation Phoenix, AZ | A | $50,000 | paid | TRANSLATIONAL RESEARCH INTO YAP1 FUSION EPENDYMOMAS | 202202729349301750 |
| 2020 | New York Medical College Valhalla, NY | A | $667,840 | paid | PEDIATRIC CANCER RESEARCH LABORATORY GRANT | 202132789349300548 |
| 2020 | Ann & Robert Lurie Children's Hospital Chicago, IL | A | $296,250 | paid | RESEARCH INTO THE EPIGENETIC TARGETED THERAPY FOR PEDIATRIC MALIGNANT GLIOMA-BROMODOMAIN INHIBITOR | 202132789349300548 |
| 2020 | Dana-Farber Cancer Institute Boston, MA | A | $168,000 | paid | RESEARCH INTO THE PROSPECTIVE VALIDATION OF A PROGNOSTIC LIQUID BIOPSY APPROACH FOR PEDIATRIC EWING SARCOMA | 202132789349300548 |
| 2020 | Case Western Reserve University School of Medicine Cleveland, OH | A | $105,000 | paid | BASIC RESEARCH SCIENCE AWARD FOR THERAPY OF OSTEOSARCOMA PULOMARY METASTASIS | 202132789349300548 |
| 2020 | Stanford University Palo Alto, CA | A | $95,500 | paid | RESEARCH INTO DEVELOPING NEW THERAPIES FOR RELAPSED ACUTE MYELOID LEUKEMIA (AML) AND ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) | 202132789349300548 |
| 2020 | Seattle Children's Hospital Seattle, WA | A | $93,750 | paid | RESEARCH INTO THE DEVELOPMENT OF TUNABLE ON-OFF CAR T CELLS FOR SAFE AND DURABLE TUMOR CONTROL. | 202132789349300548 |
| 2020 | University of Texas Md Anderson Cancer Center Houston, TX | A | $87,500 | paid | TRANSLATIONAL SCIENCE AWARD FOR NEUROBLASTOMA RELAPSE | 202132789349300548 |
| 2020 | Children's Hospital of Philadelphia Research Institute Philadelphia, PA | A | $87,500 | paid | RESEARCH INTO PRECISION MEDICINE TO EXPLOIT BCL2-FAMILY SURVIVAL DEPENDENCIES IN NEUROBLASTOMA. | 202132789349300548 |
| 2020 | Beckman Research Institute of the City of Hope Duarte, CA | U | $77,500 | paid | TRANSLATIONAL SCIENCE AWARD FOR ACUTE LYMPHOBLASTIC LEUKEMIA | 202132789349300548 |
| 2020 | Lucille Packard Foundation Palo Alto, CA | A | $75,000 | paid | RESEARCH INTO EFFECTIVE THERAPY FOR PEDIATRIC HIGH-GRADE GLIOMAS. | 202132789349300548 |
| 2020 | University of California San Francisco San Francisco, CA | A | $56,250 | paid | TRANSLATIONAL SCIENCE AWARD FOR JUVENILE MYELOMONCYTIC LEUKEMIA. | 202132789349300548 |
| 2020 | UCLA Foundation Los Angeles, CA | A | $50,000 | paid | RESEARCH INTO A MULTIDISCIPLINARY APPROACH TO SIGNIFICANTLY AND POSITIVELY IMPROVE THE QUALITY OF LIFE AND QUALITY OF CARE FOR CHILDREN AND YOUNG PEOPLE WITH CANCER. | 202132789349300548 |
| 2020 | Texas Children's Hospital Houston, TX | A | $50,000 | paid | RESEARCH INTO MOLECULAR CHARACTERIZATION OF UNDIFFERENTIATED SARCOMAS. | 202132789349300548 |
| 2020 | University of Denver Aurora, CO | A | $35,000 | paid | RESEARCH INTO ASSESSING PATIENT PREFERENCES AND AN EXISTING TOOL FOR SCREENING FOR SEXUAL DYSFUNCTION IN ADOLESCENT AND YOUNG ADULT SURVIVORS OF CHILDHOOD CANCER. | 202132789349300548 |
| 2018 | New York Medical College Valhalla, NY | A | $0 + $677,717 non-cash | paid | PEDIATRIC CANCER RESEARCH LABORATORY GRANT | 201913019349301186 |
| 2018 | Emory University Atlanta, GA | A | $0 + $35,000 non-cash | paid | EMERGING INVESTIGATOR FELLOWSHIP AWARD FOR MEDULLOBLASTOMA RECURRENCE | 201913019349301186 |
| 2018 | Memorial Sloan Kettering Cancer Center New York, NY | A | $0 + $35,000 non-cash | paid | PEDIATRIC CANCER RESEARCH GRANTS - WILM'S TUMOR | 201913019349301186 |
| 2018 | Case Western Reserve University School of Medicine Cleveland, OH | A | $0 + $150,000 non-cash | paid | BASIC RESEARCH SCIENCE AWARD FOR THERAPY OF OSTEOSARCOMA PULOMARY METASTASIS | 201913019349301186 |
| 2018 | University of Texas Md Anderson Cancer Center Houston, TX | A | $0 + $75,000 non-cash | paid | TRANSLATIONAL SCIENCE AWARD FOR NEUROBLASTOMA RELAPSE | 201913019349301186 |
| 2018 | Children's Hospital of Los Angeles Los Angeles, CA | A | $0 + $175,000 non-cash | paid | PEDIATRIC CANCER RESEARCH GRANTS - MEDULLOBLASTOMA & ACUTE LYMPHOBLASTIC LEUKEMIA | 201913019349301186 |
| 2018 | Lurie Children's Hospital Chicago, IL | A | $0 + $50,000 non-cash | paid | PEDIATRIC CANCER RESEARCH GRANTS - GLIOMAS | 201913019349301186 |
| 2018 | Massachusetts General Hospital Boston, MA | A | $0 + $35,000 non-cash | paid | EMERGING INVESTIGATOR FELLOWSHIP FOR IMPROVEMENT OF MEDULLOBLASTOMA THERAPY | 201913019349301186 |
| 2018 | Dana-Farber Cancer Institute Boston, MA | A | $0 + $75,000 non-cash | paid | PEDIATRIC CANCER RESEARCH GRANTS - EWING SARCOMA | 201913019349301186 |
| 2018 | Children's Hospitals and Clinics of Minnesota Minneapolis, MN | A | $0 + $50,000 non-cash | paid | PEDIATRIC CANCER RESEARCH GRANTS - PLEUROPULMONARY BLASTOMA | 201913019349301186 |
| 2018 | Stanford University Palo Alto, CA | A | $0 + $75,000 non-cash | paid | PEDIATRIC CANCER RESEARCH GRANTS - LEUKEMIA/LYMPHOMA | 201913019349301186 |
| 2018 | Beckman Research Institute of the City of Hope Duarte, CA | U | $0 + $75,000 non-cash | paid | TRANSLATIONAL SCIENCE AWARD FOR ACUTE LYMPHOBLASTIC LEUKEMIA | 201913019349301186 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Source filings
Every figure above is traceable to one of these IRS e-file returns by its OBJECT_ID.
| Form | Tax year | Period end | Filed | Schema | IRS OBJECT_ID |
|---|---|---|---|---|---|
| 990 | 2025 | 2025-06-30 | not stated | 2024v5.5 | 202600799349300310 |
| 990 | 2024 | 2024-06-30 | not stated | 2024v5.1 | 202521079349301112 |
| 990 | 2023 | 2023-12-31 | not stated | 2023v5.1 | 202402729349300305 |
| 990 | 2022 | 2022-12-31 | not stated | 2022v5.0 | 202322719349302127 |
| 990 | 2021 | 2021-12-31 | not stated | 2021v4.2 | 202202729349301750 |
| 990 | 2020 | 2020-12-31 | not stated | 2020v4.1 | 202132789349300548 |
| 990 | 2018 | 2018-12-31 | not stated | 2018v3.1 | 201913019349301186 |
Derived from IRS Form 990 e-file XML; recipient identities from the IRS Exempt Organizations Business Master File. Dataset version 2026.09.0, built 2026-09-03. The same rows as Parquet: manifest; as JSON: /api/funders/953772528.json.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.